Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: MRI-guided Ultrahypofractionated SBRT Prostate Program [NA]

View source ↗

Summary

This clinical trial update notes an MRI-guided ultrahypofractionated SBRT program for prostate cancer that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING